Articles tagged with Cancer
Researchers from the University of Queensland found that having more babies reduces a woman's risk of endometrial cancer by 50% compared to none. The study used genetic analysis and examined how many years women ovulated, with strong links pointing to childbirth.
Researchers have discovered that mutations in mitochondrial-related genes can trigger hyperinflammation, leading to diseases such as Crohn's disease and tuberculosis. The study found that these mutations lead to a new type of cell death called necroptosis, which causes an aggressive inflammatory immune response.
A team of scientists has discovered how cancer cells adapt to high viscosity environments, improving their invasiveness and favoring metastases. Cancer cells exploit ion transport systems to move more efficiently, while high viscosity actually promotes their migration and lung colonization.
A UCSF-led study sheds light on the mechanisms behind sex differences in ICI-induced myocarditis, a potentially fatal side effect of cancer immunotherapy. The research suggests that immune checkpoint inhibitors may interact with sex hormones to cause cardiac toxicity in female patients.
Researchers have developed a preclinical model of appendiceal cancer, which accurately recapitulates the disease's cell mix and behavior. The organotypic slice culture model offers promising new avenues for studying the pathobiology of this rare tumor and testing potential treatments.
Researchers developed a polygenic hazard score based on 290 genetic variants to predict genetic risk of lethal prostate cancer. The study analyzed nearly 591,000 men and found that the score adds considerably more information for individualized risk assessment, potentially benefiting high-risk men with accurate screening.
Research at Linköping University suggests that dense breasts have unique biological characteristics that promote cancer growth, leading to a fivefold increased risk. The study used MRI and microdialysis techniques to measure proteins in breast tissue, finding elevated levels of inflammatory markers and growth factors.
Researchers at Tokyo Medical and Dental University developed a new technique to detect breast cancer-related markers using transistors, offering a less invasive method for monitoring patients. The system successfully detected epidermal growth factor receptor expression on cancer cells.
A research group at Osaka Metropolitan University developed a nanovaccine that delivers cancer antigens to dendritic cells, inducing strong cellular immunity. The new system, using positively charged cationic lipids, increases cytokine production by approximately 100 times compared to previous designs.
Researchers found that a quarter of cancer patients want to know their life expectancy, while almost half want to know about their functional prognosis. The study suggests that doctors should consider various options for informing patients about their future to cater to individual needs.
A study by Uppsala University has identified a stem cell protein, SOX9, that makes tumor cells resistant to radiation treatment, leading to recurrence and increased mortality. The research found that SOX9 protects resting cancer cells against radiation, promoting their survival and resistance.
The TRIDENT-1 trial suggests that repotrectinib could be effective for treating ROS1 positive non-small cell lung cancer (NSCLC) in patients who have received other targeted treatments and those who have not. The drug showed promising results, with an objective response rate of 79% in patients not previously treated with a ROS TKI.
Researchers at Ludwig Chicago develop a novel nanotechnology that induces therapeutic anti-tumor immune responses and demonstrates efficacy in mouse models of multiple cancers. The nanoparticle-loaded drug activates the STING protein, promoting inflammation and driving immune cells to attack tumors.
The annual report shows a continued decline in overall cancer death rates among men, women, children, and adolescents. Additionally, there are modest improvements in survival for pancreatic cancer, with declines seen in lung cancer and melanoma.
A new study reveals that gut microbiota from patients with inflammatory bowel disease produce genotoxic metabolites called indolimines, which may contribute to the development of colorectal cancer. The study identified a previously unknown family of DNA-damaging compounds produced by the CRC-associated gut microbe Morganella morganii.
A new study identifies a specific mechanism of faulty DNA repair in tumors as a key factor in determining patient outcomes with immunotherapy. Tumors with defective DNA repair proteins had significantly better responses to immunotherapy, whereas those with silenced production of DNA repair proteins did not.
In a patient trial, the AKT inhibitor ipatasertib showed signs of effectiveness in treating advanced cancers. 22% of patients experienced tumor shrinkage, while 56% had stable disease. Further research is needed to understand why some patients responded and others did not.
Researchers controlled magnetic bacteria to cross blood vessel walls and infiltrate tumor tissue, delivering liposomes with fluorescent dye to demonstrate their ability to carry therapeutic agents. This approach may revolutionize bacterial cancer therapy by increasing efficacy and reducing side effects.
Research found that blood transfusions following solid tumor removal in pediatric oncology patients are associated with higher rates of post-surgery infectious complications, shorter disease-free intervals, and tumor recurrence. The study aims to inform thoughtful use of blood transfusion and encourage multi-center data collection.
Researchers at UCLA Jonsson Comprehensive Cancer Center and Semel Institute identified the gene P300 as a potential therapeutic target for treatment-resistant brain cancer glioblastoma multiforme. By blocking P300, tumor cells can be prevented from recovering and growing under the hostile conditions created by radiation therapy.
A recent analysis found that older U.S. adults with poor prognosis cancers had preexisting conditions such as functional impairment and difficulty with mobility before diagnosis. These conditions can impact their physical function and quality of life.
The study, led by Johanna Joyce, develops a strategy to noninvasively monitor key immune cells known as macrophages within brain and breast tumors. The researchers use nanoparticles labeled with fluorine isotopes that emit distinctive signals detectable by MRI, allowing for the direct imaging of TAMs across tumor geography.
Researchers found that endogenous retrovirus RNA is present in all non-diseased tissue types, including cerebellum and thyroid tissues. This discovery has important clinical implications for the use of HML-2 expression as a cancer biomarker or therapeutic target.
A study from Tokyo Medical and Dental University reveals that the TGF-β signaling molecule can induce EMT in oral cancer cells, leading to high motility and metastatic potential. KRTAP2-3 expression is associated with poorer overall survival, suggesting its role as a prognostic biomarker.
A new study found that sleeping five hours or less per night is associated with a higher risk of developing at least two chronic diseases over a 25-year period. This includes heart disease, cancer, and diabetes. The study analyzed data from over 7,000 men and women aged 50, 60, and 70.
Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.
A study found that Italian regions with high levels of environmental pollution have higher cancer mortality rates, even after controlling for lifestyle factors. The analysis identified specific sources of pollution associated with certain types of cancer, highlighting the need for environmental reduction and prevention to combat cancer.
Researchers found that the quality and mix of collagen in pancreatic ductal adenocarcinoma tumors affects prognosis. Patients with tumors containing cleaved Collagen I experienced poor survival prospects, while those with non-cleaved Collagen I had better outcomes.
Researchers at UNC Lineberger Comprehensive Cancer Center have found a way to overcome barriers limiting cancer immunotherapies. They discovered that activating the STING protein can increase regulatory B cells, which suppress anti-cancer immunity.
Researchers at FAU's Schmidt College of Medicine are developing a pilot program to tackle health disparities by leveraging electronic health records, artificial intelligence, and machine learning. The project aims to improve AI/ML delivery and research operations in community health centers and federally qualified health centers.
A clinical trial conducted by Salk Institute and UC San Diego Health found that time-restricted eating improved measures of health and wellbeing in firefighters. The study showed that a 10-hour eating window reduced VLDL cholesterol, improved mental health, and decreased alcohol intake.
Researchers discovered that cancer cells induce the formation of intracellular gaps in liver sinusoidal endothelial cells (LSECs), allowing them to infiltrate the liver and form new tumors. MMP9 expression in LSECs is key to this process, and a MMP9 inhibitor can prevent tumor formation.
Researchers have developed a model of how human embryos are formed, revealing that genes are switched on almost immediately after fertilization. This discovery may also shed light on the origins of cancer, which is often diagnosed at an advanced stage.
A recent study found that among US patients with cancer during the first 10 months of the COVID-19 pandemic, 16,561 deaths were attributed to cancer or COVID-19 complications. The majority of these deaths occurred in older adults and minority groups, highlighting a concerning disparity in healthcare outcomes.
The first-ever mycobiome atlas describes associations between cancers and fungi, revealing differences in community compositions across cancer types. The study found significant correlations between specific fungi and age, tumor subtypes, smoking status and survival measures.
Researchers at the University of Arizona have identified a protein called Ait1 that regulates cell growth in yeasts. This discovery presents new targets for developing antifungal drugs that can attack disease-causing yeasts while sparing human immune cells.
Researchers developed a biosensor that can detect brain cancer from minute blood samples using surface-enhanced Raman spectroscopy. The test distinguishes primary brain tumors from secondary tumors and predicts tumor location within the brain with high accuracy.
Researchers found that proteins coalesce into a liquid droplet to process and relay information in stem cells, which could be a target for cancer therapies. The droplet's unique structure enables efficient processing of proteins, making it a crucial component in cancer development.
Researchers at the University of Toledo found that consumption of highly refined fiber may increase liver cancer risk in some individuals, particularly those with a silent vascular deformity. The study discovered that high concentrations of bile acids caused by a portosystemic shunt led to the development of liver cancer.
The European Association of Urology warns that bladder cancer is often overlooked due to lack of awareness. A new survey found that over half of adults do not recognize common symptoms such as changes in urine color, leading to delayed diagnosis and poorer treatment outcomes.
A large study of former smokers found that those adhering to evidence-based recommendations for body weight, diet, physical activity, and alcohol intake had a significantly lower risk of death. The study included nearly 160,000 older U.S. adults and showed that better lifestyle habits can reduce mortality risk from various causes.
Mayo Clinic researchers identified critical genomic changes associated with abiraterone acetate/prednisone resistance in advanced prostate cancer. An 11-gene drug panel predicted a worse prognosis for a subset of patients, and whole-exome sequencing data revealed mechanisms of acquired resistance.
A study published in JCI Insight has found that genetic variation plays a crucial role in the racial disparity of esophageal cancer cases. Researchers used artificial intelligence-guided tools to pinpoint a specific type of immune cell as the disease driver, and a protective genetic factor associated with African Americans.
Researchers at UMC Utrecht will investigate how intestinal microbiota impacts cancer immunotherapy and therapy side effects. The project aims to develop microbiota-targeted therapies to improve ICI treatment effectiveness and reduce severe inflammation.
Researchers have discovered that a type of pediatric brain tumour, medulloblastoma, develops in a pre-malignant form during human fetal brain development. This finding suggests that medulloblastomas could be preventable by identifying the genetic variations that cause them and acting before they develop.
Researchers at the University of Basel have successfully differentiated triple-negative breast cancer cells into normal-like cells, opening a new avenue for treatment. The breakthrough uses inhibitors of polo-like kinase 1 to induce estrogen receptor expression, leading to reduced cell growth and tumorigenicity.
Researchers at Nagoya University have identified new agents involved in DNA damage tolerance pathways, including RFWD3, which may contribute to anticancer treatment. The study's findings suggest that inhibiting these pathways could sensitize cancer cells to conventional chemotherapeutic agents.
A team from The Institute of Industrial Science at The University of Tokyo has developed a new platform that uses organorhodium(III) phthalocyanine complexes to achieve the combination of traits necessary for photodynamic therapy. The new system shows toxicity to HeLa cells, indicating its potential as a cancer treatment.
Researchers at Ludwig Lausanne have identified a combination of three existing drugs that significantly extends survival in mouse models of GBM. The combination, which includes an antidepressant, immune checkpoint blockade antibody, and a cancer therapy analog, unleashes powerful anti-tumor immune responses.
A new study from Michigan Medicine found that adults with more chronic health conditions are at higher risk of serious financial problems, including late payments, poor credit scores, and bankruptcy. The study analyzed nearly 3 million privately insured adults and found that those with seven or more chronic conditions had three to four...
A UTHSC-led research team has been awarded $5.2 million by the National Cancer Institute to investigate the relationship between obesity and cancer risk. The team, led by Dr. Liza Makowski, aims to understand how obesity affects the immune system's ability to fight cancer.
The Montefiore Einstein Cancer Center has received a $10 million grant from the National Cancer Institute to study lung metastasis in breast cancer. The research aims to understand the mechanisms of tumor cells seeding tumors in the lungs, a key site for triple-negative breast cancer metastasis.
A new wearable device called FAST can measure tumor size changes to the hundredth of a millimeter, providing a fast, accurate, and inexpensive way to test cancer drugs. This technology represents a significant advance in cancer treatment, offering continuous monitoring, flexibility, and non-invasiveness.
Researchers create a new, non-invasive wearable device that can measure tumor size changes in real-time. The 'Flexible Autonomous Sensor measuring Tumors' (FAST) device provides continuous monitoring and accurate results, offering a promising approach to cancer treatment.
A Yale study published in PLOS ONE reveals a significant association between incarceration and higher cancer mortality among adults. Those diagnosed with invasive cancer while incarcerated and within one year after release were more likely to experience worse outcomes due to limited access to quality care, social determinants of health...
A UC San Diego study found that cancer patients experiencing housing instability had a significantly increased risk of mortality. The research suggests that integrating health and social care can improve patient outcomes by identifying and addressing underlying social risk factors.
Schwann cells in nerve healing take over immune cell functions to prevent excessive tissue damage and promote regeneration. Similarly, they may stop chronic inflammation in childhood nerve tumors, making them benign. Schwann cells can also regulate T-cell activity, potentially curbing cancer growth.
A recent study by Washington State University researchers has identified distinct genetic patterns among the most prevalent types of canine soft tissue sarcomas, potentially leading to more accurate diagnoses and effective treatments. The findings suggest that a single treatment approach may not be effective for all subtypes of the tumor.
Researchers at UVA will study organelles in cancer cells to identify new pathways for understanding and fighting cancer. By focusing on the interactions between genes, proteins, and organelles within cells, they hope to develop fresh clues about therapies.
Researchers at University of California - San Francisco have developed a new therapy that overcomes cancer cell barriers and marks them for destruction by the immune system. By pulling mutated KRAS protein to the surface, the drug acts as an “eat me” flag, allowing immunotherapy to eliminate all cells bearing this flag.